HISTOCHEMICAL DISTRIBUTION OF CA-125 AS A PROGNOSTIC INDICATOR IN PATIENTS WITH SEROUS OVARIAN-CANCER

被引:3
作者
BICHEL, P
JAKOBSEN, A
ORNTOFT, TF
机构
[1] AARHUS UNIV, AARHUS KOMMUNE HOSP, INST PATHOL, DEPT CLIN CHEM, DK-8000 AARHUS, DENMARK
[2] VEJLE CENT HOSP, INST PATHOL, AARHUS, DENMARK
[3] DANISH CANC SOC, DEPT EXPTL CLIN ONCOL, AARHUS, DENMARK
关键词
CA-125; HISTOCHEMICAL DISTRIBUTION; OVARY CARCINOMA; PROGNOSIS;
D O I
10.1111/j.1525-1438.1991.tb00040.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The study comprises 66 patients with stage Ill and IV serous ovarian carcinoma While the percentage of CA-125 positive cells and the staining intensity showed no correlation to patient survival, the pattern of CA-125 distribution, membranous versus cytoplasmic, was significantly correlated to survival. In accordance with other observations on switching of the antigen reaction f rom membrane to cytoplasm with increasing grade of atypia or malignancy, patients with membrane positive CA-125 tumors had a significantly better prognosis than did patients with CA-125 in the cytoplasm. Furthermore, there was excellent agreement between, on the one hand, the binding pattern of CA-125 and, on the other, the ploidy of the tumor cells and the HGI histopathologic grading index, both previously shown to be of prognostic significance.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 50 条
  • [11] Nadir CA125 concentration as a prognostic indicator in ovarian cancer
    Baron, AT
    Maihle, N
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (06): : 288 - 289
  • [12] CA-125 MEASUREMENTS IN OVARIAN-CANCER PATIENTS DURING THEIR 1ST POSTOPERATIVE WEEK
    MOGENSEN, O
    BROCK, A
    NYLAND, MH
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1993, 3 (01) : 54 - 56
  • [13] COMBINED EVALUATION OF SERUM CA-125 AND CAM-29 IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER
    FERDEGHINI, M
    GADDUCCI, A
    PRONTERA, C
    MALAGNINO, G
    ANNICCHIARICO, C
    PRATO, B
    BIANCHI, R
    FIORETTI, P
    TUMOR BIOLOGY, 1992, 13 (5-6) : 287 - 293
  • [14] Assessment of CA-125 area under the curve as a prognostic factor in patients with ovarian cancer
    Uzunoglu, Sernaz
    Aybatli, Aysun
    Kaplan, Petek Balkanli
    Cicin, Irfan
    Sut, Necdet
    Sayin, Cenk
    Varol, Fusun
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [15] Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer
    Piatek, Szymon
    Panek, Grzegorz
    Lewandowski, Zbigniew
    Piatek, Dominika
    Kosinski, Przemyslaw
    Bidzinski, Mariusz
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [16] The Prognostic and Predictive Value of Combined HE4 and CA-125 in Ovarian Cancer Patients
    Steffensen, Karina Dahl
    Waldstrom, Marianne
    Brandslund, Ivan
    Petzold, Max
    Jakobsen, Anders
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (09) : 1474 - 1482
  • [17] Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls
    Diaz-Padilla, Ivan
    Razak, Albiruni Ryan Abdul
    Minig, Lucas
    Bernardini, Marcus Q.
    del Campo, Josep Maria
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (01) : 15 - 20
  • [18] Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls
    Iván Díaz-Padilla
    Albiruni Ryan Abdul Razak
    Lucas Minig
    Marcus Q. Bernardini
    Josep María del Campo
    Clinical and Translational Oncology, 2012, 14 : 15 - 20
  • [19] The role of serum CA-125 levels and CA-125 tissue expression positivity in the prediction of the recurrence of stage III and IV epithelial ovarian tumors (CA-125 levels and tissue CA-125 in ovarian tumors)
    Gundogdu, Fatih
    Soylu, Ferit
    Erkan, Levent
    Tatli, Orkan
    Mavi, Sadiye
    Yavuzcan, Ali
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2011, 283 (06) : 1397 - 1402
  • [20] Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer
    Bachmann, Robert
    Brucker, Sara
    Staebler, Annette
    Kraemer, Bernhard
    Ladurner, Ruth
    Koenigsrainer, Alfred
    Wallwiener, Diethelm
    Bachmann, Cornelia
    MOLECULAR AND CLINICAL ONCOLOGY, 2021, 14 (01) : 1 - 10